Contact Members' Area Join

FAILSAFE – Fungal AMR Innovations for LMICS: Solutions and Access For Everyone

Welcome

FAILSAFE is part of a global effort to curb fungal AMR through interdisciplinary research and the development of sustainable, long-term partnerships. By supporting innovative research, FAILSAFE hopes to drive tangible improvements in the prevention, diagnosis, and treatment of fungal diseases globally.

FUNDING

NETWORK

FUNDED RESEARCH

SPOTLIGHT ON AFR

1 billion people

suffer from fungal infections each year lorem lorem lorem lorem

1.5 million deaths

occur annually due to fungal infections

Only 4 classes

of antifungal drugs

11 pathogens

exhibiting resistance to one or more antifungal agents

£3.5 million

available FAILSAFE funding for research and development to combat fungal AMR worldwide

£1.7 million awarded

in 2024 to support groundbreaking fungal AMR research